Alzheon Appoints Former GlaxoSmithKline CEO Jean-Pierre Garnier as Chairman of Board of Directors

Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced that Jean-Pierre Garnier, PhD, has been appointed Chairman of the Board of Directors of the company, according to a Business Wire press release.

Dr. Garnier brings world-class expertise and global perspective to help build Alzheon into a leading clinical-stage Alzheimer’s company.

Read the full press release here.